Napier Financial’s Pfizer PFE Stock Holding History

Napier Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Buy	4,452 +495	+13%	+$12.9K	0.02%	159
2026 Q1	$111K	Buy	+3,957	New	+$105K	0.03%	144

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Napier Financial's PFE Position: Q2 2026 in Review

Napier Financial increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $12.9K and bringing the position to 4,452 shares worth $107K. The position accounts for 0.02% of the portfolio, ranked #159.

Napier Financial first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $111K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Napier Financial held 4,452 shares of Pfizer worth $107K as of Q2 2026.
Napier Financial bought 495 Pfizer shares in Q2 2026, an estimated $12.9K.
Pfizer made up 0.02% of Napier Financial's portfolio in Q2 2026, its #159 holding.
Napier Financial first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
Napier Financial's Pfizer position peaked at $111K in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Napier Financial's 13F filing for Q2 2026, filed 31 Jul 2026.